GARY J WHITMAN to Combined Modality Therapy
This is a "connection" page, showing publications GARY J WHITMAN has written about Combined Modality Therapy.
Connection Strength
0.112
-
Ductal dilatation as the manifesting sign of invasive ductal carcinoma. J Ultrasound Med. 2005 Oct; 24(10):1413-7.
Score: 0.029
-
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer. Sci Rep. 2021 11 15; 11(1):22242.
Score: 0.022
-
Negative mammograms in symptomatic patients with breast cancer. Acad Radiol. 1998 Jan; 5(1):26-33.
Score: 0.017
-
The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. Oncologist. 2012; 17(11):1402-8.
Score: 0.012
-
Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer. Cancer Chemother Pharmacol. 1992; 31(3):213-6.
Score: 0.011
-
Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer. 2007 Dec 01; 110(11):2420-7.
Score: 0.008
-
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007 Apr; 14(4):1458-71.
Score: 0.008
-
Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer. 2003 Sep 15; 98(6):1150-60.
Score: 0.006